- Report
- May 2024
- 296 Pages
Global
From €4424EUR$5,000USD£3,826GBP
- Report
- January 2024
- 437 Pages
Global
From €4424EUR$5,000USD£3,826GBP
- Report
- May 2024
- 182 Pages
Global
From €3982EUR$4,500USD£3,443GBP
- Report
- January 2025
- 84 Pages
Vietnam
From €3097EUR$3,500USD£2,678GBP
- Report
- July 2024
- 100 Pages
Global
From €3318EUR$3,750USD£2,869GBP
- Report
- May 2025
- 62 Pages
Brazil
From €4203EUR$4,750USD£3,634GBP
- Report
- February 2024
- 70 Pages
China
From €4203EUR$4,750USD£3,634GBP
From €4203EUR$4,750USD£3,634GBP
- Report
- February 2024
- 117 Pages
Global
From €4203EUR$4,750USD£3,634GBP
- Report
- November 2023
- 209 Pages
Europe
From €3053EUR$3,450USD£2,640GBP
- Report
- October 2023
- 200 Pages
North America
From €3053EUR$3,450USD£2,640GBP
- Report
- October 2023
- 199 Pages
From €3053EUR$3,450USD£2,640GBP
- Report
- October 2023
- 210 Pages
Middle East, Africa
From €3053EUR$3,450USD£2,640GBP
- Report
- October 2023
- 225 Pages
Asia Pacific
From €3053EUR$3,450USD£2,640GBP
- Report
- July 2023
- 270 Pages
Global
From €3938EUR$4,450USD£3,405GBP
- Report
- January 2024
- 150 Pages
Global
From €3407EUR$3,850USD£2,946GBP
€4291EUR$4,850USD£3,711GBP
- Report
- June 2025
- 250 Pages
Vietnam
From €2468EUR$2,789USD£2,134GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2468EUR$2,789USD£2,134GBP
- Report
- June 2025
- 250 Pages
India
From €2468EUR$2,789USD£2,134GBP
- Report
- June 2025
- 250 Pages
Japan
From €2468EUR$2,789USD£2,134GBP

The Immunodiagnostic market is a segment of the In Vitro Diagnostics (IVD) industry. It is focused on the development and production of tests that use antibodies to detect the presence of a specific antigen in a sample. These tests are used to diagnose a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. Immunodiagnostics are also used to monitor the effectiveness of treatments and to assess the risk of developing certain diseases.
Immunodiagnostics are typically performed in a laboratory setting, using a variety of techniques such as enzyme-linked immunosorbent assays (ELISA), immunofluorescence, and immunohistochemistry. These tests are often used in combination with other diagnostic methods, such as imaging and molecular diagnostics, to provide a more comprehensive diagnosis.
Some of the major companies in the Immunodiagnostic market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more